The National Institute for Health and Care Excellence (NICE) has issued its Final Appraisal Determination (FAD) recommending FIRMAGON® (degarelix) as an option for treating advanced...
Research shows processing can affect size of nano carriers for targeted drug delivery
4/16/2014
Significant advances have been made in chemotherapy over the past decade, but targeting drugs to cancer cells while avoiding healthy tissues continues to be a major challenge.
Stratasys Ltd., a leading global provider of 3D printing and additive manufacturing solutions, has announced that Brightwake Ltd.
Popular web information on colorectal cancer is too difficult for most lay people to read and doesn't address the appropriate risks to and concerns of patients, a study by UT Southwestern Medical...
Study suggests gene panels as a useful, cheaper alternative to whole-genome sequencing
4/16/2014
As many as 10 percent of women with a personal or family history of breast or ovarian cancer have at least one genetic mutation that, if known, would prompt their doctors to recommend changes in...
True North Therapeutics, Inc., announced a publication demonstrating that the company's C1s antibody prevents the destruction of human red blood cells exposed to plasma samples of patients with a...
New blood test 'accurately predicts breast cancer recurrence'
4/15/2014
Researchers have developed a blood test that they say predicts breast cancer recurrence with up to 95% accuracy and effectively monitors patients' response to chemotherapy.
Controversial new research may overturn the standard treatment of men with advanced prostate cancer.
New potential treatment opportunities for leukemia patients
4/15/2014
The long-term survival of people suffering from chronic lymphocytic leukemia (CLL) could be increased with the development of new therapeutic strategies.
'MicroRNA' could be key target for bowel cancer treatment
4/15/2014
A tiny genetic molecule known as a microRNA plays a central role in bowel cancer and could be key to developing new treatments for the disease, a new study concludes.